Jarius, S.
Haas, J.
Paul, F.
Wildemann, B.
Funding for this research was provided by:
Dietmar Hopp Stiftung
Merck Serono
German Federal Ministry of Education and Research
Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft
Baden-Württemberg Ministry of Science, Research and the Arts
Ruprecht-Karls-Universität Heidelberg
Article History
Received: 11 October 2018
Accepted: 31 January 2019
First Online: 28 February 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: BW reports grants from German Ministry of Education and Research, grants from Dietmar Hopp Foundation, grants from Klaus Tschira Foundation, personal fees from Bayer Healthcare, personal fees from Biogen, grants and personal fees from Merck Serono, grants and personal fees from Novartis, grants and personal fees from Sanofi Genzyme, grants and personal fees from TEVA, outside the submitted work.FP has received research support from Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis/Genzyme, Merck Serono, Alexion, Chugai, Arthur Arnstein Foundation Berlin, Guthy Jackson Charitable Foundation and the US National Multiple Sclerosis Society; has received travel funding and/or speaker honoraria from Bayer, Novartis, Biogen Idec, Teva, Sanofi-Aventis/Genzyme and Merck Serono; and has consulted for Sanofi Genzyme, Biogen Idec and MedImmune; none of this is related to the present paper.The other authors report no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.